Percutaneous Repair of Calcified Valve Rings: Innovations and Clinical Outcomes in Interventional Cardiology
Main Article Content
Abstract
The advent of percutaneous repair techniques for calcified valve rings represents a significant advancement in interventional cardiology, addressing the complexities associated with valvular calcification. This article provides a comprehensive review of the current methodologies employed in the percutaneous repair of calcified valve rings, emphasizing the technological innovations, procedural strategies, and clinical outcomes. The discussion encompasses the pathophysiology of valvular calcification, patient selection criteria, and the evolution of device technology. Furthermore, it critically examines the efficacy and safety profiles of various interventional approaches, with a focus on post-procedural hemodynamic performance, long-term durability, and patient quality of life. By analyzing recent clinical trials and real-world data, this review aims to delineate best practices and future directions in the management of calcified valvular disease.
Article Details
This work is licensed under a Creative Commons Attribution 4.0 International License.
References
I. Vahanian, A.; Beyersdorf, F.; Praz, F.; Milojevic, M.; Baldus, S.; Bauersachs, J.; Capodanno, D.; Conradi, L.; De Bonis, M.; De Paulis, R.; et al. 2021 ESC/EACTS Guidelines for the management of valvular heart disease: Developed by the Task Force for the management of valvular heart disease of the European Society of Cardiology and the European Association for CardioThoracic Surgery. Eur. Heart J. 2022, 43, 561–632.
II. McInerney, A.; Marroquin-Donday, L.; Tirado-Conte, G.; Hennessey, B.; Espejo, C.; Pozo, E.; de Agustín, A.; Gonzalo, N.; Salinas, P.; Núñez-Gil, I.; et al. Transcatheter Treatment of Mitral Regurgitation. J. Clin. Med. 2022, 11, 2921.
III. Inoue, K.; Owaki, T.; Nakamura, T.; Kitamura, F.; Miyamoto, N. Clinical application of transvenous mitral commissurotomy by a new balloon catheter. J. Thorac. Cardiovasc. Surg. 1984, 87, 394–402.
IV. Iung, B.; Nicoud-Houel, A.; Fondard, O.; Akoudad, H.; Haghighat, T.; Brochet, E.; Garbarz, E.; Cormier, B.; Baron, G.; Luxereau, P.; et al. Temporal trends in percutaneous mitral commissurotomy over a 15-year period. Eur. Heart J. 2004, 25, 701–707.
V. Nowak, B.; Baykut, D.; Kaltenbach, M.; Reifart, N. Usefulness of shock wave lithotripsy as pretreatment for balloon valvuloplasty in calcified mitral stenosis. Am. J. Cardiol. 1989, 63, 996–997.
VI. Forero, M.N.T.; Daemen, J. The Coronary Intravascular Lithotripsy System. Interv. Cardiol. 2019, 14, 174–181.
VII. Kassimis, G.; Didagelos, M.; De Maria, G.L.; Kontogiannis, N.; Karamasis, G.V.; Katsikis, A.; Sularz, A.; Karvounis, H.; Kanonidis, I.; Krokidis, M.; et al. Shockwave Intravascular Lithotripsy for the Treatment of Severe Vascular Calcification. Angiology 2020, 71, 677–688.
VIII. Eng, M.H.; Villablanca, P.; Wang, D.D.; Frisoli, T.; Lee, J.; O’Neill, W.W. Lithotripsy-Facilitated Mitral Balloon Valvuloplasty for Senile Degenerative Mitral Valve Stenosis. JACC Cardiovasc. Interv. 2019, 12, e133–e134.
IX. Sharma, A.; Kelly, R.; Mbai, M.; Chandrashekhar, Y.; Bertog, S. Transcatheter Mitral Valve Lithotripsy as a Pretreatment to Percutaneous Balloon Mitral Valvuloplasty for Heavily Calcified Rheumatic Mitral Stenosis. Circ. Cardiovasc. Interv. 2020, 13, e009357.
X. Sanz-Ruiz, R.; González-Mansilla, A.; Rivera-Juárez, A.; Bermejo, J.; Fernández-Avilés, F. 1-Step Percutaneous Treatment of Heavily Calcified Left-Heart Valve Stenoses. JACC Cardiovasc. Interv. 2021, 14, e335–e337.
XI. Holtz, J.E.; Upadhyaya, D.S.; Cohen, B.E.; Na, B.; Schiller, N.B.; Whooley, M.A. Mitral annular calcium, inducible myocardial ischemia, and cardiovascular events in outpatients with coronary heart disease (from the Heart and Soul Study). Am. J. Cardiol. 2012, 109, 1092–1096.
XII. Chehab, O.; Roberts-Thomson, R.; Bivona, A.; Gill, H.; Patterson, T.; Pursnani, A.; Grigoryan, K.; Vargas, B.; Bokhary, U.; Blauth, C.; et al. Management of Patients with Severe Mitral Annular Calcification. J. Am. Coll. Cardiol. 2022, 80, 722–738.
XIII. Cheng, R. How to Manage Mitral Stenosis Due to Mitral Annular Calcification. Curr. Cardiol. Rep. 2021, 23, 148.
XIV. Khan, J.M.; Babaliaros, V.C.; Greenbaum, A.B.; Foerst, J.R.; Yazdani, S.; McCabe, J.M.; Paone, G.; Eng, M.H.; Leshnower, B.G.; Gleason, P.T.; et al. Anterior Leaflet Laceration to Prevent Ventricular Outflow Tract Obstruction During Transcatheter Mitral Valve Replacement. J. Am. Coll. Cardiol. 2019, 73, 2521–2534.
XV. Wang, D.D.; Guerrero, M.; Eng, M.H.; Eleid, M.F.; Meduri, C.U.; Rajagopal, V.; Yadav, P.K.; Fifer, M.A.; Palacios, I.F.; Rihal, C.S.; et al. Alcohol septal ablation to prevent left ventricular outflow tract obstruction during transcatheter mitral valve replacement: First-in-man study. JACC Cardiovasc. Interv. 2019, 12, 1268–1279.
XVI. Hamid, U.I.; Gregg, A.; Ball, P.; Owens, C.; Manoharan, G.; Spence, M.S.; Jeganathan, R. Open transcatheter valve implantation for mitral annular calcification: One-year outcomes. JTCVS Tech. 2021, 10, 254–261